Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy.

Journal Article (Journal Article)

Thirty adults with large cell lymphoma predominantly localized to the mediastinum diagnosed at the Massachusetts General Hospital between 1976 and 1985 were identified. The median age of the 20 females and 10 males was 34 years. All but one presented with symptoms due to an enlarging mediastinal mass, which was localized in 22 patients (73%) and exceeded 10 cm in maximal diameter in 65%. Superior vena cava syndrome and large pleural and pericardial effusions were common. Employing CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) and consolidation radiation therapy in most cases, 80% achieved a complete remission and 59% survive failure-free at 5 years by actuarial calculation. The size of the mediastinal mass adversely affected failure-free survival (89% vs. 40%, P less than 0.05). No other pretreatment risk factor predicted outcome, but more intense chemotherapy was associated with improved survival (P = 0.035). Large cell mediastinal lymphoma is a locally invasive, often bulky malignancy with a predilection for young women; disease of low or moderate bulk is curable with full dose CHOP chemotherapy and consolidation radiation, but bulky disease requires more aggressive treatment.

Full Text

Duke Authors

Cited Authors

  • Jacobson, JO; Aisenberg, AC; Lamarre, L; Willett, CG; Linggood, RM; Miketic, LM; Harris, NL

Published Date

  • November 1, 1988

Published In

Volume / Issue

  • 62 / 9

Start / End Page

  • 1893 - 1898

PubMed ID

  • 3167803

International Standard Serial Number (ISSN)

  • 0008-543X

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19881101)62:9<1893::aid-cncr2820620904>;2-x


  • eng

Conference Location

  • United States